We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With Encompass Health (EHC) Q4 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Encompass Health (EHC - Free Report) will announce quarterly earnings of $1.02 per share in its forthcoming report, representing an increase of 7.4% year over year. Revenues are projected to reach $1.38 billion, increasing 10.4% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some Encompass Health metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Revenues- Inpatient Rehabilitation' should arrive at $1.33 billion. The estimate points to a change of +9.6% from the year-ago quarter.
Analysts forecast 'Revenues- Outpatient and other' to reach $37.68 million. The estimate indicates a year-over-year change of +25.6%.
Analysts expect 'Net patient revenue per discharge' to come in at $21,059.38. The estimate is in contrast to the year-ago figure of $20,538.
It is projected by analysts that the 'Total Discharges' will reach 63,313. Compared to the present estimate, the company reported 59,247 in the same quarter last year.
Encompass Health shares have witnessed a change of +10.5% in the past month, in contrast to the Zacks S&P 500 composite's +1.7% move. With a Zacks Rank #4 (Sell), EHC is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stay Ahead of the Game With Encompass Health (EHC) Q4 Earnings: Wall Street's Insights on Key Metrics
Analysts on Wall Street project that Encompass Health (EHC - Free Report) will announce quarterly earnings of $1.02 per share in its forthcoming report, representing an increase of 7.4% year over year. Revenues are projected to reach $1.38 billion, increasing 10.4% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some Encompass Health metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Revenues- Inpatient Rehabilitation' should arrive at $1.33 billion. The estimate points to a change of +9.6% from the year-ago quarter.
Analysts forecast 'Revenues- Outpatient and other' to reach $37.68 million. The estimate indicates a year-over-year change of +25.6%.
Analysts expect 'Net patient revenue per discharge' to come in at $21,059.38. The estimate is in contrast to the year-ago figure of $20,538.
It is projected by analysts that the 'Total Discharges' will reach 63,313. Compared to the present estimate, the company reported 59,247 in the same quarter last year.
View all Key Company Metrics for Encompass Health here>>>
Encompass Health shares have witnessed a change of +10.5% in the past month, in contrast to the Zacks S&P 500 composite's +1.7% move. With a Zacks Rank #4 (Sell), EHC is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>